ArticleEVALUATION OF THE POSSIBLE ROLE OF IL-17 AND ITS RECEPTOR IL-17R IN THE PATHOGENESIS OF ORAL LICHEN PLANUS
ArticleEVALUATION OF THE POSSIBLE ROLE OF IL-17 AND ITS RECEPTOR IL-17R IN THE PATHOGENESIS OF ORAL LICHEN PLANUS
ArticleSalivary level of interleukin-17 in patients having atrophic and erosive oral lichen planus before and after treatment with topical steroids (A Controlled clinical trial)
ArticleSalivary level of interleukin-17 in patients having atrophic and erosive oral lichen planus before and after treatment with topical steroids (A Controlled clinical trial)
ArticleImmunohistochemical study of nuclear factor kappa-light chain enhancer of activated B cells (NF-KB) and interleukin-17 (IL-17) in oral lichen planus
ArticleImmunohistochemical study of nuclear factor kappa-light chain enhancer of activated B cells (NF-KB) and interleukin-17 (IL-17) in oral lichen planus
ArticleAssessment of Serum Level of Squamous Cell Carcinoma Antigen II in Patients with Lichen Planus
ArticleAssessment of Serum Level of Squamous Cell Carcinoma Antigen II in Patients with Lichen Planus
ArticleINTERLEUKIN 23 AND INTERLEUKIN17 IN PSORIASIS, ATOPIC DERMATITIS AND LICHEN PLANUS: A SEROLOGICAL STUDY
ArticleINTERLEUKIN 23 AND INTERLEUKIN17 IN PSORIASIS, ATOPIC DERMATITIS AND LICHEN PLANUS: A SEROLOGICAL STUDY
ArticleAssessment of Serum Interleukin-23 in Acne Vulgaris Patients and Its Correlation with Disease Severity
ArticleAssessment of Serum Interleukin-23 in Acne Vulgaris Patients and Its Correlation with Disease Severity